chr1-20314568-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039500.3(VWA5B1):c.539G>A(p.Gly180Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000098 in 1,551,586 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001039500.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWA5B1 | NM_001039500.3 | c.539G>A | p.Gly180Asp | missense_variant | 4/22 | ENST00000289815.13 | NP_001034589.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWA5B1 | ENST00000289815.13 | c.539G>A | p.Gly180Asp | missense_variant | 4/22 | 5 | NM_001039500.3 | ENSP00000289815.9 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152130Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000689 AC: 107AN: 155360Hom.: 0 AF XY: 0.000570 AC XY: 47AN XY: 82502
GnomAD4 exome AF: 0.0000958 AC: 134AN: 1399338Hom.: 0 Cov.: 32 AF XY: 0.0000913 AC XY: 63AN XY: 690178
GnomAD4 genome AF: 0.000118 AC: 18AN: 152248Hom.: 1 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74418
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.539G>A (p.G180D) alteration is located in exon 4 (coding exon 3) of the VWA5B1 gene. This alteration results from a G to A substitution at nucleotide position 539, causing the glycine (G) at amino acid position 180 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at